Revolutionizing Healthcare: Advances in Stem Cell and Gene Therapies
March 4, 2025 — The global stem cell therapy market is projected to reach $28.89 billion by 2030, fueled by advancements in regenerative medicine. Companies like ADIA Nutrition, CRISPR Therapeutics, Mesoblast Limited, and bluebird bio are leading the way in developing innovative treatments. Stay informed about these advancements to understand the evolving landscape of healthcare and potential investment prospects.